This will conclude the whittling process of the 30 Dow Jones Industrials with the last six below. Although the Dow has done very well in the last six months there still appears to be plenty of value here from everything I am able to surmise.

So far I have whittled the Dow down to six stocks: Alcoa Aluminum (NYSE: AA), American International Group (NYSE: AIG), Caterpillar Inc. (NYSE: CAT), The Walt Disney Company (NYSE: DIS), Exxon Mobil (NYSE: XOM) and The Home Depot (NYSE: HD). You can link to the previous posts, Part 1, Part 2, Part 3, Part 4 or Part 5 for your own review and comments.

Pfizer (NYSE: PFE) is a tough one for me to review because there are a lot of mixed signals in the data and the market about Pfizer concerning its pipeline of products. Most notably it has a P/S of 4.14 (TTM) which would place it outside of my consideration by a factor of two under most situations. This is a result of declining sales, but the decline has not hurt earnings in a big way, so the P/E has been coming down as a result. The P/E is about average for the DOW but historically low for Pfizer. If the "pipeline" is truly bare then this trend will continue. However, the stock is supported by a 4.2% yield, almost no long-term debt, and trailing margins that are HUGE at about 40%. Back to the less than appealing issues: PFE has a price-to-cash-flow ratio of almost 15, too high for me. In the long run Pfizer may be a great hold. If you are looking for a solid dividend payer with resistance to much downside risk it would be great for your Roth IRA, but here and now, it might be a short term value trap. In the absence of an acquisition or great new drug where is the upside?